{"id":19386,"date":"2016-12-19T15:55:51","date_gmt":"2016-12-19T15:55:51","guid":{"rendered":"https:\/\/farmanuario.com\/wp-content\/uploads\/2016\/12\/epinefrina-slide.jpg"},"modified":"2018-05-31T20:02:04","modified_gmt":"2018-05-31T20:02:04","slug":"mylan-abaratara-epipen-en-eeuu-a-pacientes-de-bajos-ingresos-ante-polemica-2-2","status":"inherit","type":"attachment","link":"https:\/\/farmanuario.com\/tendencias\/mylan-abaratara-epipen-en-eeuu-a-pacientes-de-bajos-ingresos-ante-polemica-2-2\/","title":{"rendered":"MYLAN ABARATAR\u00c1 \u00b4\u00b4EPIPEN\u00b4\u00b4 EN EEUU A PACIENTES DE BAJOS INGRESOS ANTE POL\u00c9MICA"},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_acf_changed":false,"_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0},"class_list":["post-19386","attachment","type-attachment","status-inherit","hentry"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v25.1 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>MYLAN ABARATAR\u00c1 \u00b4\u00b4EPIPEN\u00b4\u00b4 EN EEUU A PACIENTES DE BAJOS INGRESOS ANTE POL\u00c9MICA - Farmanuario<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/farmanuario.com\/tendencias\/wp-content\/uploads\/2016\/12\/epinefrina-slide.jpg\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"MYLAN ABARATAR\u00c1 \u00b4\u00b4EPIPEN\u00b4\u00b4 EN EEUU A PACIENTES DE BAJOS INGRESOS ANTE POL\u00c9MICA - Farmanuario\" \/>\n<meta property=\"og:description\" content=\"EFE\/EUA CARIBE SHM04 WASHINGTON, DC (EEUU), 25\/8\/2016.- Imagen de un auto-inyector para ataques de alergia &quot;EpiPen&quot; en una escuela de Provo, Utah, este jueves 25 de agosto, 2016. El gigante farmac\u00e9utico Mylan reducir\u00e1 el coste de su popular medicamento a personas con bajos recursos en EE.UU. ante el alud de presiones pol\u00edticas generadas por su encarecimiento de m\u00e1s de 500% desde 2007. En un comunicado, la compa\u00f1\u00eda sali\u00f3 hoy al paso de la pol\u00e9mica suscitada por el \u00faltimo aumento en 100 d\u00f3lares del precio de este f\u00e1rmaco que salva vidas, indicando que no bajar\u00e1 el precio general de &quot;EpiPen&quot; en EE.UU., pero ampliar\u00e1 los programas que ya tiene para facilitar el acceso a este f\u00e1rmaco a las personas con menos recursos o con nula o escasa cobertura del seguro para medicamentos. EFE\/GEORGE FREY\" \/>\n<meta property=\"og:url\" content=\"https:\/\/farmanuario.com\/tendencias\/wp-content\/uploads\/2016\/12\/epinefrina-slide.jpg\" \/>\n<meta property=\"og:site_name\" content=\"Farmanuario\" \/>\n<meta property=\"article:modified_time\" content=\"2018-05-31T20:02:04+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/farmanuario.com\/tendencias\/wp-content\/uploads\/2016\/12\/epinefrina-slide.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1170\" \/>\n\t<meta property=\"og:image:height\" content=\"300\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/farmanuario.com\/tendencias\/wp-content\/uploads\/2016\/12\/epinefrina-slide.jpg\",\"url\":\"https:\/\/farmanuario.com\/tendencias\/wp-content\/uploads\/2016\/12\/epinefrina-slide.jpg\",\"name\":\"MYLAN ABARATAR\u00c1 \u00b4\u00b4EPIPEN\u00b4\u00b4 EN EEUU A PACIENTES DE BAJOS INGRESOS ANTE POL\u00c9MICA - Farmanuario\",\"isPartOf\":{\"@id\":\"https:\/\/farmanuario.com\/tendencias\/#website\"},\"datePublished\":\"2016-12-19T15:55:51+00:00\",\"dateModified\":\"2018-05-31T20:02:04+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/farmanuario.com\/tendencias\/wp-content\/uploads\/2016\/12\/epinefrina-slide.jpg#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/farmanuario.com\/tendencias\/wp-content\/uploads\/2016\/12\/epinefrina-slide.jpg\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/farmanuario.com\/tendencias\/wp-content\/uploads\/2016\/12\/epinefrina-slide.jpg#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Portada\",\"item\":\"https:\/\/farmanuario.com\/tendencias\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"MYLAN ABARATAR\u00c1 \u00b4\u00b4EPIPEN\u00b4\u00b4 EN EEUU A PACIENTES DE BAJOS INGRESOS ANTE POL\u00c9MICA\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/farmanuario.com\/tendencias\/#website\",\"url\":\"https:\/\/farmanuario.com\/tendencias\/\",\"name\":\"Farmanuario\",\"description\":\"Informaci\u00f3n sobre Farmacos y Medicamentos\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/farmanuario.com\/tendencias\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"MYLAN ABARATAR\u00c1 \u00b4\u00b4EPIPEN\u00b4\u00b4 EN EEUU A PACIENTES DE BAJOS INGRESOS ANTE POL\u00c9MICA - Farmanuario","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/farmanuario.com\/tendencias\/wp-content\/uploads\/2016\/12\/epinefrina-slide.jpg","og_locale":"es_ES","og_type":"article","og_title":"MYLAN ABARATAR\u00c1 \u00b4\u00b4EPIPEN\u00b4\u00b4 EN EEUU A PACIENTES DE BAJOS INGRESOS ANTE POL\u00c9MICA - Farmanuario","og_description":"EFE\/EUA CARIBE SHM04 WASHINGTON, DC (EEUU), 25\/8\/2016.- Imagen de un auto-inyector para ataques de alergia \"EpiPen\" en una escuela de Provo, Utah, este jueves 25 de agosto, 2016. El gigante farmac\u00e9utico Mylan reducir\u00e1 el coste de su popular medicamento a personas con bajos recursos en EE.UU. ante el alud de presiones pol\u00edticas generadas por su encarecimiento de m\u00e1s de 500% desde 2007. En un comunicado, la compa\u00f1\u00eda sali\u00f3 hoy al paso de la pol\u00e9mica suscitada por el \u00faltimo aumento en 100 d\u00f3lares del precio de este f\u00e1rmaco que salva vidas, indicando que no bajar\u00e1 el precio general de \"EpiPen\" en EE.UU., pero ampliar\u00e1 los programas que ya tiene para facilitar el acceso a este f\u00e1rmaco a las personas con menos recursos o con nula o escasa cobertura del seguro para medicamentos. EFE\/GEORGE FREY","og_url":"https:\/\/farmanuario.com\/tendencias\/wp-content\/uploads\/2016\/12\/epinefrina-slide.jpg","og_site_name":"Farmanuario","article_modified_time":"2018-05-31T20:02:04+00:00","og_image":[{"width":1170,"height":300,"url":"https:\/\/farmanuario.com\/tendencias\/wp-content\/uploads\/2016\/12\/epinefrina-slide.jpg","type":"image\/jpeg"}],"twitter_card":"summary_large_image","schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/farmanuario.com\/tendencias\/wp-content\/uploads\/2016\/12\/epinefrina-slide.jpg","url":"https:\/\/farmanuario.com\/tendencias\/wp-content\/uploads\/2016\/12\/epinefrina-slide.jpg","name":"MYLAN ABARATAR\u00c1 \u00b4\u00b4EPIPEN\u00b4\u00b4 EN EEUU A PACIENTES DE BAJOS INGRESOS ANTE POL\u00c9MICA - Farmanuario","isPartOf":{"@id":"https:\/\/farmanuario.com\/tendencias\/#website"},"datePublished":"2016-12-19T15:55:51+00:00","dateModified":"2018-05-31T20:02:04+00:00","breadcrumb":{"@id":"https:\/\/farmanuario.com\/tendencias\/wp-content\/uploads\/2016\/12\/epinefrina-slide.jpg#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/farmanuario.com\/tendencias\/wp-content\/uploads\/2016\/12\/epinefrina-slide.jpg"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/farmanuario.com\/tendencias\/wp-content\/uploads\/2016\/12\/epinefrina-slide.jpg#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Portada","item":"https:\/\/farmanuario.com\/tendencias\/"},{"@type":"ListItem","position":2,"name":"MYLAN ABARATAR\u00c1 \u00b4\u00b4EPIPEN\u00b4\u00b4 EN EEUU A PACIENTES DE BAJOS INGRESOS ANTE POL\u00c9MICA"}]},{"@type":"WebSite","@id":"https:\/\/farmanuario.com\/tendencias\/#website","url":"https:\/\/farmanuario.com\/tendencias\/","name":"Farmanuario","description":"Informaci\u00f3n sobre Farmacos y Medicamentos","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/farmanuario.com\/tendencias\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"}]}},"description":{"rendered":"<p class=\"attachment\"><a href='https:\/\/farmanuario.com\/tendencias\/wp-content\/uploads\/2016\/12\/epinefrina-slide.jpg'><img loading=\"lazy\" decoding=\"async\" width=\"300\" height=\"77\" src=\"https:\/\/farmanuario.com\/tendencias\/wp-content\/uploads\/2016\/12\/epinefrina-slide-300x77.jpg\" class=\"attachment-medium size-medium\" alt=\"\" srcset=\"https:\/\/farmanuario.com\/tendencias\/wp-content\/uploads\/2016\/12\/epinefrina-slide-300x77.jpg 300w, https:\/\/farmanuario.com\/tendencias\/wp-content\/uploads\/2016\/12\/epinefrina-slide-800x205.jpg 800w, https:\/\/farmanuario.com\/tendencias\/wp-content\/uploads\/2016\/12\/epinefrina-slide-768x197.jpg 768w, https:\/\/farmanuario.com\/tendencias\/wp-content\/uploads\/2016\/12\/epinefrina-slide-1024x263.jpg 1024w, https:\/\/farmanuario.com\/tendencias\/wp-content\/uploads\/2016\/12\/epinefrina-slide.jpg 1170w\" sizes=\"auto, (max-width: 300px) 100vw, 300px\" \/><\/a><\/p>\n"},"caption":{"rendered":"<p>EFE\/EUA CARIBE SHM04 WASHINGTON, DC (EEUU), 25\/8\/2016.- Imagen de un auto-inyector para ataques de alergia \u00abEpiPen\u00bb en una escuela de Provo, Utah, este jueves 25 de agosto, 2016. El gigante farmac\u00e9utico Mylan reducir\u00e1 el coste de su popular medicamento a personas con bajos recursos en EE.UU. ante el alud de presiones pol\u00edticas generadas por su encarecimiento de m\u00e1s de 500% desde 2007. En un comunicado, la compa\u00f1\u00eda sali\u00f3 hoy al paso de la pol\u00e9mica suscitada por el \u00faltimo aumento en 100 d\u00f3lares del precio de este f\u00e1rmaco que salva vidas, indicando que no bajar\u00e1 el precio general de \u00abEpiPen\u00bb en EE.UU., pero ampliar\u00e1 los programas que ya tiene para facilitar el acceso a este f\u00e1rmaco a las personas con menos recursos o con nula o escasa cobertura del seguro para medicamentos. EFE\/GEORGE FREY<\/p>\n"},"alt_text":"","media_type":"image","mime_type":"image\/jpeg","media_details":{"width":1170,"height":300,"file":"2016\/12\/epinefrina-slide.jpg","sizes":{"woocommerce_thumbnail":{"file":"epinefrina-slide-520x300.jpg","width":520,"height":300,"uncropped":false,"mime_type":"image\/jpeg","source_url":"https:\/\/farmanuario.com\/tendencias\/wp-content\/uploads\/2016\/12\/epinefrina-slide-520x300.jpg"},"woocommerce_gallery_thumbnail":{"file":"epinefrina-slide-100x100.jpg","width":100,"height":100,"mime_type":"image\/jpeg","source_url":"https:\/\/farmanuario.com\/tendencias\/wp-content\/uploads\/2016\/12\/epinefrina-slide-100x100.jpg"},"woocommerce_single":{"file":"epinefrina-slide-800x205.jpg","width":800,"height":205,"mime_type":"image\/jpeg","source_url":"https:\/\/farmanuario.com\/tendencias\/wp-content\/uploads\/2016\/12\/epinefrina-slide-800x205.jpg"},"thumbnail":{"file":"epinefrina-slide-150x150.jpg","width":150,"height":150,"mime_type":"image\/jpeg","source_url":"https:\/\/farmanuario.com\/tendencias\/wp-content\/uploads\/2016\/12\/epinefrina-slide-150x150.jpg"},"medium":{"file":"epinefrina-slide-300x77.jpg","width":300,"height":77,"mime_type":"image\/jpeg","source_url":"https:\/\/farmanuario.com\/tendencias\/wp-content\/uploads\/2016\/12\/epinefrina-slide-300x77.jpg"},"medium_large":{"file":"epinefrina-slide-768x197.jpg","width":768,"height":197,"mime_type":"image\/jpeg","source_url":"https:\/\/farmanuario.com\/tendencias\/wp-content\/uploads\/2016\/12\/epinefrina-slide-768x197.jpg"},"large":{"file":"epinefrina-slide-1024x263.jpg","width":1024,"height":263,"mime_type":"image\/jpeg","source_url":"https:\/\/farmanuario.com\/tendencias\/wp-content\/uploads\/2016\/12\/epinefrina-slide-1024x263.jpg"},"shop_thumbnail":{"file":"epinefrina-slide-100x100.jpg","width":100,"height":100,"mime_type":"image\/jpeg","source_url":"https:\/\/farmanuario.com\/tendencias\/wp-content\/uploads\/2016\/12\/epinefrina-slide-100x100.jpg"},"shop_catalog":{"file":"epinefrina-slide-520x300.jpg","width":520,"height":300,"uncropped":false,"mime_type":"image\/jpeg","source_url":"https:\/\/farmanuario.com\/tendencias\/wp-content\/uploads\/2016\/12\/epinefrina-slide-520x300.jpg"},"shop_single":{"file":"epinefrina-slide-800x205.jpg","width":800,"height":205,"mime_type":"image\/jpeg","source_url":"https:\/\/farmanuario.com\/tendencias\/wp-content\/uploads\/2016\/12\/epinefrina-slide-800x205.jpg"},"post-thumbnail":{"file":"epinefrina-slide-727x300.jpg","width":727,"height":300,"mime_type":"image\/jpeg","source_url":"https:\/\/farmanuario.com\/tendencias\/wp-content\/uploads\/2016\/12\/epinefrina-slide-727x300.jpg"},"portfolio-two-column":{"file":"epinefrina-slide-1110x300.jpg","width":1110,"height":300,"mime_type":"image\/jpeg","source_url":"https:\/\/farmanuario.com\/tendencias\/wp-content\/uploads\/2016\/12\/epinefrina-slide-1110x300.jpg"},"portfolio-three-column":{"file":"epinefrina-slide-720x300.jpg","width":720,"height":300,"mime_type":"image\/jpeg","source_url":"https:\/\/farmanuario.com\/tendencias\/wp-content\/uploads\/2016\/12\/epinefrina-slide-720x300.jpg"},"portfolio-four-column":{"file":"epinefrina-slide-750x300.jpg","width":750,"height":300,"mime_type":"image\/jpeg","source_url":"https:\/\/farmanuario.com\/tendencias\/wp-content\/uploads\/2016\/12\/epinefrina-slide-750x300.jpg"},"blog-two-column":{"file":"epinefrina-slide-1110x300.jpg","width":1110,"height":300,"mime_type":"image\/jpeg","source_url":"https:\/\/farmanuario.com\/tendencias\/wp-content\/uploads\/2016\/12\/epinefrina-slide-1110x300.jpg"},"blog-three-column":{"file":"epinefrina-slide-720x300.jpg","width":720,"height":300,"mime_type":"image\/jpeg","source_url":"https:\/\/farmanuario.com\/tendencias\/wp-content\/uploads\/2016\/12\/epinefrina-slide-720x300.jpg"},"blog-four-column":{"file":"epinefrina-slide-750x300.jpg","width":750,"height":300,"mime_type":"image\/jpeg","source_url":"https:\/\/farmanuario.com\/tendencias\/wp-content\/uploads\/2016\/12\/epinefrina-slide-750x300.jpg"},"full":{"file":"epinefrina-slide.jpg","width":1170,"height":300,"mime_type":"image\/jpeg","source_url":"https:\/\/farmanuario.com\/tendencias\/wp-content\/uploads\/2016\/12\/epinefrina-slide.jpg"}},"image_meta":{"aperture":"0","credit":"EFE","camera":"","caption":"EFE\/EUA CARIBE SHM04 WASHINGTON, DC (EEUU), 25\/8\/2016.- Imagen de un auto-inyector para ataques de alergia \"EpiPen\" en una escuela de Provo, Utah, este jueves 25 de agosto, 2016. El gigante farmac\u00e9utico Mylan reducir\u00e1 el coste de su popular medicamento a personas con bajos recursos en EE.UU. ante el alud de presiones pol\u00edticas generadas por su encarecimiento de m\u00e1s de 500% desde 2007. En un comunicado, la compa\u00f1\u00eda sali\u00f3 hoy al paso de la pol\u00e9mica suscitada por el \u00faltimo aumento en 100 d\u00f3lares del precio de este f\u00e1rmaco que salva vidas, indicando que no bajar\u00e1 el precio general de \"EpiPen\" en EE.UU., pero ampliar\u00e1 los programas que ya tiene para facilitar el acceso a este f\u00e1rmaco a las personas con menos recursos o con nula o escasa cobertura del seguro para medicamentos. EFE\/GEORGE FREY","created_timestamp":"0","copyright":"","focal_length":"0","iso":"0","shutter_speed":"0","title":"MYLAN ABARATAR\u00c1 \u00b4\u00b4EPIPEN\u00b4\u00b4 EN EEUU A PACIENTES DE BAJOS INGRESOS ANTE POL\u00c9MICA","orientation":"0","keywords":["Sanidad y salud","Medicamentos, farmacia"]}},"post":null,"source_url":"https:\/\/farmanuario.com\/tendencias\/wp-content\/uploads\/2016\/12\/epinefrina-slide.jpg","_links":{"self":[{"href":"https:\/\/farmanuario.com\/tendencias\/wp-json\/wp\/v2\/media\/19386","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/farmanuario.com\/tendencias\/wp-json\/wp\/v2\/media"}],"about":[{"href":"https:\/\/farmanuario.com\/tendencias\/wp-json\/wp\/v2\/types\/attachment"}],"author":[{"embeddable":true,"href":"https:\/\/farmanuario.com\/tendencias\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/farmanuario.com\/tendencias\/wp-json\/wp\/v2\/comments?post=19386"}]}}